Clinical Trial Update: SI-6603 Versus Placebo in Patients With Lumbar Disc Herniation [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial updates report a Phase 2/3 study of SI-6603 versus placebo in patients with lumbar disc herniation (lumbar vertebra hernia) that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Disc Herniation

Drugs mentioned

• SI-6603

Snippet

Sponsor: Seikagaku Corporation | Conditions: Lumbar Vertebra Hernia | Phase 2, Phase 3 | Status: COMPLETED